<DOC>
	<DOCNO>NCT02956044</DOCNO>
	<brief_summary>The purpose study examine drug-drug interaction body give study drug , bexagliflozin , three commonly use ant-diabetic medication , metformin , glimepiride sitagliptin . The study also evaluate safe study drug well study drug tolerate take metformin , glimepiride sitagliptin .</brief_summary>
	<brief_title>Interaction Bexagliflozin With Metformin , Glimepiride Sitagliptin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>1 . Subjects bodymass index ( BMI ) 18.0 kg/m2 32.0 kg/m2 2 . Subjects nonsmoker least 3 month prior screen 3 . Subjects willing able confine clinical research facility require protocol 1 . Subjects clinically significant history allergy drug latex . 2 . Subjects history alcohol drug dependence past 12 month . 3 . Subjects donate significant amount blood past 2 month 4 . Female subject pregnant breastfeed 5 . Subjects willing use adequate form birth control study 30 day discharge clinic 6 . Subjects take investigational drug past 30 day 7 halflives investigational drug , whichever longer 7 . Subjects previously receive antidiabetic medication , include metformin , sitagliptin , glimepiride drug class ( i.e . biguanides , DPP4 inhibitor sulfonylureas ) , SGLT2 inhibitor , past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>